Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, Liver Glycogen synthase activity, and β-oxidation in fructose-fed rats
- 1 December 1995
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 44 (12), 1626-1630
- https://doi.org/10.1016/0026-0495(95)90085-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose toleranceDiabetes Research and Clinical Practice, 1994
- Effect of Gemfibrozil Treatment in Sulfonylurea-Treated Patients with Noninsulin-Dependent Diabetes Mellitus*Journal of Clinical Endocrinology & Metabolism, 1991
- In vitro studies on the action of CS-045, a new antidiabetic agentMetabolism, 1990
- Improvement of Glucose Tolerance in NIDDM by Clofibrate Randomized Double-Blind StudyDiabetes Care, 1988
- Mechanism of insulin resistance in fructose-fed ratsMetabolism, 1982
- Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: Heterogeneity monooxygenase responsesPharmacological Research Communications, 1981
- Hepatic fatty acid oxidation and ketogenesis after clofibrate treatmentBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1978
- Induction of hyperglyceridemia by fructose in the ratLife Sciences, 1965
- Liquid scintillation counting of C14O2 with phenethylamineAnalytical Biochemistry, 1961
- Colorimetric Method for Determination of Sugars and Related SubstancesAnalytical Chemistry, 1956